Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Hepatology
General Primary Care
Questions discussed in this category
Is there a role for use of GLP-1/GIP receptor agonists in the management of substance use disorders, whether or not they meet other inclusion criteria for their use?
2 Answers available
How do you determine whether to limit volume removal during therapeutic paracentesis in a patient without acute or chronic kidney disease?
1 Answer available
23705
23133
Papers discussed in this category
Drug and alcohol dependence, 2024 Sep 07
Potential role of glucagon-like peptide-1 (GLP-1) receptor agonists in substance use disorder: A systematic review of randomized trials.
JAMA psychiatry, 2025 Apr 01
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial.
Related Topics in Hepatology
General Hepatology
Gastroenterology
Metabolic Dysfunction-Associated Liver Diseases
Viral Hepatitis
Autoimmune Liver Disease
Alcohol-associated Liver Disease
Genetic Liver Disease
Portal Hypertension
Liver Tumors
Transplant Hepatology